stockrowBioMarin Pharmaceutical Inc.
BMRN Healthcare Biotechnology
BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- −296.6%
- Free cash flow
- −52.3%
- Total debt
- +599.5%
Quarter to September 2026, against a year earlier
Follow BMRN
Alert me
BioMarin Pharmaceutical Inc. (BMRN) Operating margin
BioMarin Pharmaceutical Inc.'s operating margin over the twelve months to 30 September 2026 was 3.12%, down 9.6 percentage points from fiscal 2025 (12.7%). Over the past ten years it has ranged from −71.9% (fiscal 2016) to 17.0% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 12.7% | (4.26) |
| FY2024 | 17.0% | 9.29 |
| FY2023 | 7.68% | 0.00 |
| FY2022 | 7.68% | 12.14 |
| FY2021 | −4.46% | (2.13) |
| FY2020 | −2.33% | 3.57 |
| FY2019 | −5.90% | 2.38 |
| FY2018 | −8.28% | (7.16) |
| FY2017 | −1.12% | 70.82 |
| FY2016 | −71.9% | (59.50) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −8.01% | (19.22) |
| Jun 2026 | 11.2% | (5.71) |
| Mar 2026 | 16.9% | 22.02 |
| Dec 2025 | −5.10% | 0.92 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| TECH Bio-Techne Corp compare | 20.7% |
| TGTX TG Therapeutics, Inc. compare | 17.1% |
| CAI Caris Life Sciences,�Inc. compare | 13.4% |
| BMRN BioMarin Pharmaceutical Inc. | 3.12% |
| PCVX Vaxcyte, Inc. compare | 0.00% |
| SMMT Summit Therapeutics PLC compare | 0.00% |
| KYMR Kymera Therapeutics, Inc. compare | 0.00% |
| TWST Twist Bioscience Corporation compare | −33.6% |
| IBRX ImmunityBio, Inc. compare | −151.9% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on BMRN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement